Providing High-Quality Products Centered on “Creativity, Speed, and Reliability” and Making Proposals to Healthcare
First written in FY2017. 17 of 19 entries say "Restated". Latest entry: FY2025.
2 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「With its management philosophy, vision and principles of conduct as its basic management policies, our group works to achieve sound corporate growth and enhance corporate value while building the trust of shareholders and medical professionals.」
The disclosure reaffirms the policy of contributing to society through healthcare, “Trust and Support,” and providing high-quality products and services based on creativity, speed and reliability. - FY2024-Q3RestatedAnnual report
「Against this backdrop, our group is pursuing further business expansion by providing high-quality products and services to medical institutions in accordance with our principles of conduct, toward achieving the medium-term management plan “NEXT300,” announced in December 2021.」
The Company continues its policy of pursuing business expansion by providing high-quality products and services to medical institutions in accordance with its principles of conduct. - FY2024-Q2RestatedAnnual report
「Against this backdrop, our group is pursuing further business expansion by providing high-quality products and services to medical institutions in accordance with our principles of conduct, toward achieving the medium-term management plan “NEXT300,” announced in December 2021.」
The Company continues its policy of pursuing business expansion by providing high-quality products and services to medical institutions in accordance with its principles of conduct. - FY2024-Q1RestatedAnnual report
「Against this backdrop, our group is pursuing further business expansion by providing better products to medical institutions in accordance with our principles of conduct, toward achieving the medium-term management plan “NEXT300,” announced in December 2021.」
The Company continues its policy of pursuing business expansion by providing better products to medical institutions in accordance with its principles of conduct. - FY2023-Q2RestatedAnnual report
「Against this backdrop, our group formulated the medium-term management plan “NEXT300,” setting a target of ¥30 billion in net sales. With the management philosophy of contributing to society through healthcare and becoming a company that earns support, our group is pursuing further business expansion by providing high-quality products to medical institutions.」
The disclosure continues to state the management philosophy of contributing to society through healthcare and becoming a company that earns support, together with business expansion through high-quality products. - FY2023-Q1ReframedAnnual report
「Our group formulated the medium-term management plan “NEXT300,” setting a target of ¥30 billion in net sales. With the management philosophy of contributing to society through healthcare and becoming a company that earns support, our group is pursuing further business expansion by providing high-quality products to medical institutions.」
In addition to the basic policy based on the previous corporate principles of “Creativity, Speed and Reliability,” the disclosure explicitly states a management philosophy of contributing to society through healthcare and becoming a company that earns support, broadening the policy to include business expansion through high-quality products. - FY2022RestatedAnnual report
「Guided by the corporate principles of “Creativity, Speed and Reliability,” our group’s basic policy is to provide high-quality products to medical institutions and to be a company that can make proposals in response to advances in medical care.」
The Company continues its basic policy of providing high-quality products and making proposals to the medical community based on its corporate principles. - FY2021RestatedAnnual report
「Guided by the corporate principles of “Creativity, Speed and Reliability,” our group’s basic policy is to provide high-quality products to medical institutions and to be a company that can make proposals in response to advances in medical care.」
The Company continues its basic policy of providing high-quality products and making proposals to the medical community based on its corporate principles. - FY2020-Q3RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The Company continues initiatives aligned with its basic policy of providing high-quality products and proposing new products with built-in safety. - FY2020-Q2RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The Company continues initiatives aligned with its basic policy of providing high-quality products and proposing new products with built-in safety. - FY2020-Q1RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The Company continues initiatives aligned with its basic policy of providing high-quality products and proposing new products with built-in safety. - FY2019-Q3RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to provide new products with the safety features needed to address advances in medical care.」
The Company continues initiatives aligned with its basic policy of providing high-quality products and new products with built-in safety. - FY2019-Q2RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to provide new products with the safety features needed to address advances in medical care.」
The Company continues initiatives aligned with its basic policy of providing high-quality products and new products with built-in safety. - FY2019-Q1RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to provide new products with the safety features needed to address advances in medical care.」
The Company continues initiatives aligned with its basic policy of providing high-quality products and new products with built-in safety. - FY2018RestatedAnnual report
「Guided by the corporate principles of “Creativity, Speed and Reliability,” our group’s basic policy is to provide high-quality products to medical institutions and to be a company that can make proposals in response to advances in medical care. Under this policy, our group works to achieve sound corporate growth and enhance corporate value while building the trust of shareholders and medical professionals.」
The Company continues its policy of providing high-quality products and making proposals to the medical community based on its corporate principles, while emphasizing corporate value enhancement and trust. - FY2018-Q3RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The Company continues initiatives aligned with its basic policy of providing high-quality products and proposing new products with built-in safety. - FY2018-Q2RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The Company continues initiatives aligned with its basic policy of providing high-quality products and proposing new products with built-in safety. - FY2018-Q1RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The Company continues initiatives aligned with its basic policy of providing high-quality products and proposing new products with built-in safety. - FY2017First statedAnnual report
「Guided by the corporate principles of “Creativity, Speed and Reliability,” our group’s basic policy is to provide high-quality products to medical institutions and to be a company that can make proposals in response to advances in medical care. Under this policy, our group works to achieve sound corporate growth and enhance corporate value while building the trust of shareholders and medical professionals.」
For the first time, the disclosure explicitly identified as basic policies the provision of high-quality products, proposals to the medical community, enhancement of corporate value and building the trust of stakeholders, based on the corporate principles.